Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
OSTEOSET is a synthetic, resorbable bone graft substitute composed of medical-grade calcium sulfate. It is designed to fill bone voids or defects in the skeletal system that are not intrinsic to the stability of the bone structure. Upon implantation, the calcium sulfate pellets or paste provide an osteoconductive scaffold for bone ingrowth and are gradually resorbed by the body at a rate nearly equivalent to the rate of new bone formation. It is commonly used in orthopedic surgery for treating fractures with bone defects, tumor resections, and osteomyelitis. While primarily a physical scaffold, it is often used as a carrier for other therapeutic agents, such as antibiotics in the OSTEOSET T formulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calcium sulfate.